계명대학교 의학도서관 Repository

Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418)

Metadata Downloads
Author(s)
Yeon-Joo KimWon ParkBoram HaBoram ParkJungnam JooTae Hyun KimIn Hae ParkKeun Seok LeeEun Sook LeeKyung Hwan ShinHaeyoung KimJeong Il YuDoo Ho ChoSeung Jae HuhChan Woo WeeKyubo KimKyung Ran ParkYong Bae KimSung Ja AhnJong Hoon LeeJin Hee KimMison ChunHyung-Sik LeeJung Soo KimJihye Cha
Keimyung Author(s)
Kim, Jin Hee
Department
Dept. of Radiation Oncology (방사선종양학)
Journal Title
Cancer Research and Treatment
Issued Date
2017
Volume
49
Issue
4
Keyword
Breast neoplasmsDisease-free survivalRadiotherapyRecurrenceSurvivalTaxane
Abstract
PURPOSE:

The purpose of this study was to evaluate the impact of postmastectomy radiotherapy (PMRT) on loco-regional recurrence-free survival (LRRFS), disease-free survival (DFS), and overall survival (OS) in pT1-2N1 patients treated with taxane-based chemotherapy.

MATERIALS AND METHODS:

We retrospectively reviewed the medical data of pathological N1 patients who were treated with modified radical mastectomy and adjuvant taxane-based chemotherapy in 12 hospitals between January 2006 and December 2010.

RESULTS:

We identified 714 consecutive patients. The median follow-up duration was 69 months (range, 1 to 114 months) and the 5-year LRRFS, DFS, and OS rates were 97%, 94%, and 98%, respectively, in patients who received PMRT (PMRT [+]). The corresponding figures were 96%, 90%, and 96%, respectively, in patients who did not receive PMRT (PMRT [-]). PMRT had no significant impact on survival. Upon multivariable analysis, only the histological grade (HG) was statistically significant as a prognostic factor for LRRFS and DFS. In a subgroup analysis of HG 3 patients, PMRT (+) showed better DFS (p=0.081).

CONCLUSION:

PMRT had no significant impact on LRRFS, DFS, or OS in pT1-2N1 patients treated with taxane-based chemotherapy. PMRT showed a marginal benefit for DFS in HG 3 patients. Randomized studies are needed to confirm the benefit of PMRT in high risk patients, such as those with HG 3.
Keimyung Author(s)(Kor)
김진희
Publisher
School of Medicine (의과대학)
Citation
Yeon-Joo Kim et al. (2017). Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418). Cancer Research and Treatment, 49(4), 927–936. doi: 10.4143/crt.2016.508
Type
Article
ISSN
1598-2998
DOI
10.4143/crt.2016.508
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/41394
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.